Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/08/2012US8173722 Adhesive compositions for use in surgical therapy
05/08/2012US8173711 Agent for relief or prevention of xerostomia
05/08/2012US8173710 Bicyclic sphingosine 1-phosphate analogs
05/08/2012US8173709 Anti-infective methods for treating pathogen-induced disordered tissues
05/08/2012US8173708 Method and composition for administering an NMDA receptor antagonist to a subject
05/08/2012US8173707 Ophthalmologic irrigation solutions and method
05/08/2012US8173706 L-ornithine phenyl acetate and methods of making thereof
05/08/2012US8173705 Agent for alleviating wrinkles
05/08/2012US8173704 Difluorophenol derivatives and their use
05/08/2012US8173703 Skin treatments with carboxylic acid-substituted idebenone derivatives
05/08/2012US8173702 Pesticidal composition and method for controlling harmful insects
05/08/2012US8173701 Pesticidal composition and method for controlling harmful insects
05/08/2012US8173700 Salts of substituted allophanates and their use in drugs
05/08/2012US8173699 Compounds for the treatment of inflammatory diseases
05/08/2012US8173698 Fluorescent probes; solid phase synthesis; kits
05/08/2012US8173697 Alkoxyalkyl-substituted cyclic keto-enols
05/08/2012US8173696 Inhibitors of cysteine proteases and methods of use thereof
05/08/2012US8173695 Kappa selective opioid receptor antagonist
05/08/2012US8173694 Therapeutic agent
05/08/2012US8173693 Benzenesulfonamide derivatives and pharmaceutical composition thereof
05/08/2012US8173692 De novo synthesis of bacteriochlorins
05/08/2012US8173691 De novo synthesis of bacteriochlorins
05/08/2012US8173690 Compounds, compositions and methods of using same for modulating uric acid levels
05/08/2012US8173689 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
05/08/2012US8173688 Thiazole compounds, and compositions and methods using same
05/08/2012US8173687 Compounds as cannabinoid receptor ligands
05/08/2012US8173686 Use of picoplatin to treat colorectal cancer
05/08/2012US8173685 Pleuromutilin derivatives and their use as antimicrobials
05/08/2012US8173684 Pyridone derivatives as p38α MAPK inhibitors
05/08/2012US8173683 Methods for treating cognitive disorders
05/08/2012US8173682 Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
05/08/2012US8173680 Cannabinoid receptor modulators
05/08/2012US8173679 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
05/08/2012US8173678 Kappa opioid receptor ligands
05/08/2012US8173677 Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
05/08/2012US8173676 Benzyl, amines, a process for their production and their use as anti-inflammatory agents
05/08/2012US8173675 Substituted amino-thiourea compounds for combating animal pests
05/08/2012US8173674 Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
05/08/2012US8173673 Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof
05/08/2012US8173672 Quinolizidinone M1 receptor positive allosteric modulators
05/08/2012US8173671 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
05/08/2012US8173669 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
05/08/2012US8173668 Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma
05/08/2012US8173667 1-Aza-bicyclo[2.2.2]octane and 1-aza-bicyclo[2.2.1]heptane derivatives; psychotic, psychological, nervous system and neurodegenerative disorders; nicotinic receptor mediated diseases
05/08/2012US8173666 Oligomer-opioid agonist conjugates
05/08/2012US8173665 I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
05/08/2012US8173664 Modified pyrimidine glucocorticoid receptor modulators
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173662 Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
05/08/2012US8173661 Alpha-IIB-beta-3 inhibitors and uses thereof
05/08/2012US8173660 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof
05/08/2012US8173659 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors
05/08/2012US8173658 Diazabicycylic aryl derivatives and their medical use
05/08/2012US8173657 Imidazoquinoxaline compounds as immunomodulators
05/08/2012US8173656 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
05/08/2012US8173655 Bicyclic anilide heterocyclic CGRP receptor antagonists
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173653 Pyridiazinone derivatives for the treatment of tumours
05/08/2012US8173652 Isoxazole-isoxazoles and isoxazole-isothiazoles
05/08/2012US8173651 Pyridine compounds
05/08/2012US8173650 Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
05/08/2012US8173649 Glucokinase activator
05/08/2012US8173648 1,2,3,4-tetrahydroisoquinoline derivatives, preparation process therefor and pharmaceutical composition containing the same
05/08/2012US8173647 PI 3-kinase inhibitors and methods of their use
05/08/2012US8173646 FAB I inhibitors
05/08/2012US8173645 Glucokinase activators
05/08/2012US8173644 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
05/08/2012US8173643 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof
05/08/2012US8173642 Aminodihydrothiazine derivatives
05/08/2012US8173640 Compositions and methods for treating, reducing, ameliorating, or preventing infections
05/08/2012US8173639 Isoquinolinone derivatives as NK3 antagonists
05/08/2012US8173638 Compounds which modulate the CB2 receptor
05/08/2012US8173637 Stabilized atypical antipsychotic formulation
05/08/2012US8173636 Hydroxylthienoquinolones and related compounds as anti-infective agents
05/08/2012US8173635 Kinase inhibitors
05/08/2012US8173634 Polymorphic form of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic
05/08/2012US8173633 Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof
05/08/2012US8173632 Process for the modification of the solid state of a compound and co-amorphous compositions produced with same
05/08/2012US8173631 Cyclic amine compounds
05/08/2012US8173629 Method of treatment using fatty acid synthesis inhibitors
05/08/2012US8173628 Steroidal antiestrogens and antiandrogens and uses thereof
05/08/2012US8173627 Neuroprotective effect of solubilized UDCA in focal ischemic model
05/08/2012US8173626 Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
05/08/2012US8173625 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
05/08/2012US8173624 Methods of using substituted tetracycline compounds to modulate RNA
05/08/2012US8173623 Process for preparation of HIV protease inhibitors
05/08/2012US8173621 Nucleoside cyclicphosphates
05/08/2012US8173620 BHQ-caged nucleotide probes photolysable by two-photon excitation
05/08/2012US8173619 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
05/08/2012US8173618 Nutraceuticals including folate, vitamin E, and acetyl-L-carnitine, and pharmaceuticals including 3-deaza-adenosine, N-acetyl-L-cysteine, and S-adenosylmethionine; Alzheimer's disease; amyotrophic lateral sclerosis (ALS)
05/08/2012US8173616 RNA-induced translational silencing and cellular apoptosis
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173614 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
05/08/2012US8173612 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis
05/08/2012US8173609 Macrolides useful against inflammatory and allergic diseases
05/08/2012US8173608 Compound having cyclic structure and use thereof
05/08/2012US8173607 Promoter for the production of hyaluronic acid containing ginsenoside compound K
05/08/2012US8173606 Sulfated oligosaccharide derivatives
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173592 Method for a programmed controlled ovarian stimulation protocol
1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 7860